Improving P. aeruginosa detection with breath-based diagnostics.

Our team has a list of exhaled breath biomarkers that we think can diagnose P. aeruginosa lung infections in patients with cystic fibrosis. The aim of our study is to evaluate those biomarkers in patients at six cystic fibrosis centers in the USA and Canada.


If you are a patient at the following CF Centers, you can ask you care provider to see if you are eligible to participate in this study.